Key result
IMV linked to ~25% lower 30-day readmissions vs. NIV in acute decompensated heart failure.
Why the study?
Respiratory compromise requiring ventilatory support is common in ADHF, and NIV may improve outcomes and reduce mortality compared with IMV, but the association between ventilation modality and 30-day all-cause readmission required evaluation.
Does invasive mechanical ventilation reduce 30-day all-cause readmission compared to noninvasive ventilation in adults hospitalized with acute decompensated heart failure?
Cohort (n=74,431)
Yes
Does invasive mechanical ventilation reduce 30-day all-cause readmission compared to noninvasive ventilation in adults hospitalized with acute decompensated heart failure?
In patients hospitalized with acute decompensated heart failure, invasive mechanical ventilation is associated with higher in-hospital mortality and costs but lower 30-day readmission rates compared to noninvasive ventilation, likely reflecting survivor bias and higher rates of discharge to skilled care facilities.
Should not yet change ventilation strategy in acute decompensated heart failure; leaves open confounding by survivor bias and illness severity.
Background: Respiratory compromise requiring ventilatory support is common in acute decompensated heart failure (ADHF). Noninvasive ventilation (NIV) may improve outcomes and reduce mortality compared with invasive mechanical ventilation (IMV). This study evaluated the association between ventilation modality and 30-day all-cause readmission. Methods: Using data from the 2016–2017 Nationwide Readmissions Database, adults aged 18 years or older who were hospitalized with a principal diagnosis of ADHF and received ventilatory support were identified. The primary outcome was 30-day all-cause readmission. Secondary outcomes included in-hospital mortality, length of stay, hospitalization charges, and discharge disposition. Results: Among 74 431 included patients, IMV use was linked to significantly worse in-hospital outcomes. In-hospital mortality was higher with IMV (33 vs. 6.6%; P < 0.001). Median length of stay was longer (10 vs. 5 days; P < 0.001), and hospitalization charges were greater ($124 832 vs. $43 298; P < 0.001). Non-home discharges were more frequent in the IMV group (62 vs. 34%; P < 0.001). Despite these adverse findings, IMV patients had lower 30-day all-cause readmission rates compared with NIV (14 vs. 19%; P < 0.001). Conclusion: IMV in ADHF is associated with higher mortality, longer hospitalizations, and increased costs but lower 30-day readmissions. Hospitals caring for these sicker patients, often teaching institutions, may face disproportionate financial penalties. Risk adjustment of Hospital Readmission Reduction Program metrics for ventilation modality and discharge disposition should be considered.
No takes yet. Share an insight, caveat, or question.
Raja et al. (2026) conducted a cohort in Acute decompensated heart failure (ADHF) (n=74,431). Invasive mechanical ventilation vs. Noninvasive ventilation was evaluated on 30-day all-cause readmission (OR 0.75, 95% CI 0.69-0.82, p=<0.001). Invasive mechanical ventilation was associated with lower odds of 30-day all-cause readmission (OR 0.75) compared with noninvasive ventilation in patients with acute decompensated heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: